ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Psychiatry

Top Psychiatry Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHAEL KWIAT MD

Psychiatry

5,148

$859K

455
372 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

42%
prescriptions for brand name drugs

Avg: 22%

$167
Average prescription price

Avg: $115

USHA KASTURIRANGAN M.D.

Psychiatry

5,134

$812K

238
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 22%

$158
Average prescription price

Avg: $115

LEE SILVERMAN M.D.

Psychiatry

5,128

$625K

264
37 are 65+

15%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$122
Average prescription price

Avg: $115

LUIS BIRD M.D.

Psychiatry

5,103

$504K

394
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 22%

$99
Average prescription price

Avg: $115

ANJANEYULU KARUMUDI MD

Psychiatry

5,029

$508K

280
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 22%

$101
Average prescription price

Avg: $115

JIMMY IBIKUNLE MD

Psychiatry

5,005

$721K

230
28 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 22%

$144
Average prescription price

Avg: $115

VERNON KRATZ M.D.

Psychiatry

4,964

$483K

275
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$97
Average prescription price

Avg: $115

KEVIN STOCKTON MD

Psychiatry

4,961

$589K

374
30 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$119
Average prescription price

Avg: $115

TANIA MARTINEZ-JIMENEZ M.D.

Psychiatry

4,959

$442K

332
58 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$89
Average prescription price

Avg: $115

JOSEPHINE POBRE-SO M.D.

Psychiatry

4,952

$502K

312
129 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 22%

$101
Average prescription price

Avg: $115

ALTHEA DONOVAN M.D.

Psychiatry

4,925

$519K

213
41 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 22%

$105
Average prescription price

Avg: $115

MUHAMAD ALY RIFAI MD

Psychiatry

4,901

$559K

416
62 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 22%

$114
Average prescription price

Avg: $115

JESUS HERRERA MD

Psychiatry

4,883

$223K

306
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

11%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $115

O'CONNELL MILES M.D.

Psychiatry

4,854

$455K

241
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 22%

$94
Average prescription price

Avg: $115

JANE JESSE MD

Psychiatry

4,834

$598K

370
48 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 22%

$124
Average prescription price

Avg: $115

MICHAEL CARVELL MD

Psychiatry

4,833

$787K

267
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 22%

$163
Average prescription price

Avg: $115

RAVINDRANATH KOLLI M.D.

Psychiatry

4,807

$605K

263
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 22%

$126
Average prescription price

Avg: $115

FRANK YOHE M.D.

Psychiatry

4,779

$543K

279
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

16%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$114
Average prescription price

Avg: $115

JACK MANNHEIMER M.D., P.C.

Psychiatry

4,681

$509K

427
207 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 22%

$109
Average prescription price

Avg: $115

NELSON ASANTE MD

Psychiatry

4,653

$286K

277
0 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

12%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $115

SACHIDANAND KAMTAM MD

Psychiatry

4,635

$360K

285
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$78
Average prescription price

Avg: $115

GREGORY SULLIVAN MD

Psychiatry

4,633

$480K

243
55 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 22%

$104
Average prescription price

Avg: $115

YURY YAROSLAVSKY M.D.

Psychiatry

4,614

$425K

248
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 22%

$92
Average prescription price

Avg: $115

M IHTESHAM JANJUA MD

Psychiatry

4,602

$628K

166
31 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 22%

$137
Average prescription price

Avg: $115

SHEIKH AFZAL MD

Psychiatry

4,596

$465K

243
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 22%

$101
Average prescription price

Avg: $115

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank